文献速递脑血管病

I-ACQUIRE疗法家长视角:一项随机对照试验的体验分析

Parent Perspectives on I-ACQUIRE Therapy
RSS 订阅 · Stroke

本研究基于美国15中心I-ACQUIRE 3期随机对照试验(NCT03910075),分析167名围产期动脉缺血性卒中偏瘫婴幼儿家长的体验数据。与常规治疗相比,中剂量和高剂量I-ACQUIRE组家长报告治疗无明确获益的担忧比例更低(≤4% vs 18%),对治疗有用、有趣、重要和愉快的积极感受比例更高。所有组中部分家长(<52%)报告治疗相关压力、困难和疲劳。

要点

  • 与常规治疗相比,I-ACQUIRE组家长对治疗无获益的担忧更少(≤4% vs 18%)。
  • I-ACQUIRE组家长对治疗有用、有趣、重要和愉快的积极感受比例更高。
  • 所有组中均有部分家长报告治疗相关压力、困难和疲劳,比例<52%。

核心结论

  • I-ACQUIRE组家长比常规治疗组家长报告更高的积极感受和显著更少的对治疗缺乏获益的担忧。
  • 所有组中部分家长报告治疗相关压力、困难和疲劳,比例低于52%。

研究设计与样本

  • 基于美国15中心I-ACQUIRE 3期随机对照试验(2019–2025,NCT03910075)的家长体验数据。
  • 167名围产期动脉缺血性卒中偏瘫婴幼儿的家长全部同意孩子随机分配至常规治疗、中剂量I-ACQUIRE(3小时/天,5天/周,共4周)或高剂量I-ACQUIRE(6小时/天)。

主要发现

  • 中剂量组(56名)和高剂量组(58名)家长报告治疗未产生明确获益的担忧比例≤4%,常规治疗组(53名)为18%。
  • I-ACQUIRE组家长报告对孩子-治疗师互动的担忧比例≤2%,常规治疗组为24%;对家长-治疗师互动的担忧比例≤2%,常规治疗组为6%。
  • I-ACQUIRE组家长认为治疗有用(94%–98% vs 83%)、有趣(96%–98% vs 79%)、重要(94%–98% vs 85%)、有趣味(78%–84% vs 53%)、提供安慰(72%–83% vs 47%)和放松获益(28%–31% vs 17%)的比例高于常规治疗组。
  • 所有组中报告角色有压力(I-ACQUIRE 26%–28%,常规治疗32%)、困难(I-ACQUIRE 35%–48%,常规治疗38%)和疲劳(I-ACQUIRE 48%–52%,常规治疗43%)的比例相似。
  • 一般生活压力评分大多处于中等范围类别,各组相似。

临床怎么用

  • 临床决策时应考虑家长对I-ACQUIRE疗法的积极体验和较少的担忧,同时告知部分家长可能经历治疗相关压力、困难和疲劳。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. BACKGROUND:Although Constraint-Induced Movement Therapy is increasingly recommended as an evidence-based, intensive treatment for children with hemiparesis, parent perspectives are lacking. I-ACQUIRE, a multicomponent form of Constraint-Induced Movement Therapy, involves substantial parent participation. Child outcomes from the United States 15-site I-ACQUIRE phase 3 clinical trial (2019–2025), partnered with a Parent Council, are presented elsewhere. Here, we examine complementary lived-experience parent data.METHODS:All parents (167) of infants/toddlers with perinatal arterial ischemic stroke and hemiparesis consented to child random assignment to usual treatment (UT), moderate-dose I-ACQUIRE (3 h/d, 5 d/wk over 4 weeks), or high-dose I-ACQUIRE (6 h/d). Parents completed assessments about life- and therapy-related stress, treatment concerns, observations of child progress, and perceived therapy-related responsibilities.RESULTS:Parents of children in the I-ACQUIRE moderate-dose (56) and high-dose group (58), compared with UT (53), reported lower rates of concerns or problems that therapy did not produce clear benefits (≤4% versus 18%), child-therapist interactions (≤2% versus 24%), and parent-therapist interactions (≤2% versus 6%). I-ACQUIRE versus UT parents had higher proportions of positive feelings that therapy was useful (94%–98% versus 83%); interesting (96%–98% versus 79%), important (94%–98% versus 85%), and fun (78%–84% versus 53%); and provided comforting (72%–83% versus 47%) and relaxing benefits (28%–31% versus 17%). In all groups, similar proportions reported their role was stressful (I-ACQUIRE 26%–28%, UT 32%), difficult (I-ACQUIRE 35%–48%, UT 38%), and tiring (I-ACQUIRE 48%–52%, UT 43%). General life stress scores were mostly in the moderate-range category, similar across groups.CONCLUSIONS:Parents of I-ACQUIRE children reported higher positive feelings and notably fewer concerns about lack of benefits compared with UT. Across all groups, some parents (<52%) reported treatment-related stress, difficulty, and fatigue. These findings provide new perspectives from parents’ lived experiences to help families and clinicians in treatment decision-making.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: NCT03910075.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Parent Perspectives on I-ACQUIRE Therapy

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。